Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 8 recruiting now later-stage tilt small index

Brain Disease: later-stage trial registry

8 of 9 indexed Brain Disease trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 8 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Brain Disease: 9 US clinical trials tracked, 8 recruiting.

Brain Disease is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Neurological Disorders and Stroke (NINDS), running 4 of these trials.

Enrollment posture brief

Registry condition brain-disease

OPEN 8 | RECR 89% | LATE 1 | EARLY 0 | RANK #1916 | SPON 4

Nearest open-share peer: Acute Spinal Cord Injury (89% recruiting · 9 trials)

Brain Disease (this)89%Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Brain Disease

Brain Disease lists 8 open slots (89% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Brain Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Brain Disease is recruiting above its size-band peers.

    8 of 9 indexed trials (88.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Brain Disease research.

    National Institute of Neurological Disorders and Stroke (NINDS) accounts for 4 of 9 trials (44.4%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Brain Disease enrolment sits around 130 participants.

    Median target enrolment is 130 among the 9 trials that report a genuine target (sentinel values excluded). 4 of those (44.4%) plan for fewer than 100 participants.

  4. Brain Disease splits between interventional and observational designs.

    5 interventional and 4 observational studies make up this index (55.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 41

Open and recent trials

9 total, page 1 of 1

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on Brain Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Deep Brain Stimulation (DBS) of the Motor Thalamus Device
2 trials
Pre-injected group with PET insert Diagnostic test
1 trials
Injected radiotracer with PET Insert Diagnostic test
1 trials
Vericiguat Drug
1 trials
Transcranial Magnetic Stimulation Device
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Brain Disease trials. A trial with sites in several states counts in each.

Maryland 4 trials
Pennsylvania 3 trials
Tennessee 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Brain Disease page

9 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Brain Disease condition card totals 9 registered trials; most-linked intervention Deep Brain Stimulation (DBS) of the Motor Thalamus; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.